169 related articles for article (PubMed ID: 24173284)
21. Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression.
Chao C; Herr D; Chun J; Xu Y
EMBO J; 2006 Jun; 25(11):2615-22. PubMed ID: 16757976
[TBL] [Abstract][Full Text] [Related]
22. Characterization of human breast cancer cell lines for the studies on p53 in chemical carcinogenesis.
Huovinen M; Loikkanen J; Myllynen P; Vähäkangas KH
Toxicol In Vitro; 2011 Aug; 25(5):1007-17. PubMed ID: 21457773
[TBL] [Abstract][Full Text] [Related]
23. The p53 inhibitor Mdm4 cooperates with multiple genetic lesions in tumourigenesis.
Xiong S; Pant V; Zhang Y; Aryal NK; You MJ; Kusewitt D; Lozano G
J Pathol; 2017 Mar; 241(4):501-510. PubMed ID: 27925213
[TBL] [Abstract][Full Text] [Related]
24. p53 DNA binding cooperativity is essential for apoptosis and tumor suppression in vivo.
Timofeev O; Schlereth K; Wanzel M; Braun A; Nieswandt B; Pagenstecher A; Rosenwald A; Elsässer HP; Stiewe T
Cell Rep; 2013 May; 3(5):1512-25. PubMed ID: 23665223
[TBL] [Abstract][Full Text] [Related]
25. In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models.
Kenzelmann Broz D; Attardi LD
Carcinogenesis; 2010 Aug; 31(8):1311-8. PubMed ID: 20097732
[TBL] [Abstract][Full Text] [Related]
26. Analysing p53 tumour suppressor functions in mice.
Sluss HK; Jones SN
Expert Opin Ther Targets; 2003 Feb; 7(1):89-99. PubMed ID: 12556205
[TBL] [Abstract][Full Text] [Related]
27. Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling.
Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Opavsky R
EBioMedicine; 2021 Jan; 63():103191. PubMed ID: 33418509
[TBL] [Abstract][Full Text] [Related]
28. Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression.
Bouwman P; Drost R; Klijn C; Pieterse M; van der Gulden H; Song JY; Szuhai K; Jonkers J
J Pathol; 2011 May; 224(1):10-21. PubMed ID: 21404276
[TBL] [Abstract][Full Text] [Related]
29. Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover.
Dumaz N; Milne DM; Jardine LJ; Meek DW
Biochem J; 2001 Oct; 359(Pt 2):459-64. PubMed ID: 11583595
[TBL] [Abstract][Full Text] [Related]
30. Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors.
Min JN; Huang L; Zimonjic DB; Moskophidis D; Mivechi NF
Oncogene; 2007 Aug; 26(35):5086-97. PubMed ID: 17310987
[TBL] [Abstract][Full Text] [Related]
31. DNA repair-deficient Xpa/p53 knockout mice are sensitive to the non-genotoxic carcinogen cyclosporine A: escape of initiated cells from immunosurveillance?
van Kesteren PC; Beems RB; Luijten M; Robinson J; de Vries A; van Steeg H
Carcinogenesis; 2009 Mar; 30(3):538-43. PubMed ID: 19136475
[TBL] [Abstract][Full Text] [Related]
32. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
[TBL] [Abstract][Full Text] [Related]
33. Post-translational modification of p53 in tumorigenesis.
Bode AM; Dong Z
Nat Rev Cancer; 2004 Oct; 4(10):793-805. PubMed ID: 15510160
[TBL] [Abstract][Full Text] [Related]
34. p53QS: an old mutant teaches us new tricks.
Johnson TM; Attardi LD
Cell Cycle; 2005 Jun; 4(6):731-4. PubMed ID: 15908788
[TBL] [Abstract][Full Text] [Related]
35. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
36. Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors.
Horton SJ; Giotopoulos G; Yun H; Vohra S; Sheppard O; Bashford-Rogers R; Rashid M; Clipson A; Chan WI; Sasca D; Yiangou L; Osaki H; Basheer F; Gallipoli P; Burrows N; Erdem A; Sybirna A; Foerster S; Zhao W; Sustic T; Petrunkina Harrison A; Laurenti E; Okosun J; Hodson D; Wright P; Smith KG; Maxwell P; Fitzgibbon J; Du MQ; Adams DJ; Huntly BJP
Nat Cell Biol; 2017 Sep; 19(9):1093-1104. PubMed ID: 28825697
[TBL] [Abstract][Full Text] [Related]
37. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
[TBL] [Abstract][Full Text] [Related]
38. Effect of intragastric application of N-methylnitrosourea in p53 knockout mice.
Ohgaki H; Fukuda M; Tohma Y; Huang H; Stoica G; Tatematsu M; Donehower LA
Mol Carcinog; 2000 Jun; 28(2):97-101. PubMed ID: 10900466
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53.
Sugikawa E; Yazaki N; Tsunoda S; Nakanishi N; Ohashi M
Biochem Biophys Res Commun; 1999 Aug; 261(2):256-63. PubMed ID: 10425175
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous phosphorylation of p53 at serine 15 and 20 induces apoptosis in human glioma cells by increasing expression of pro-apoptotic genes.
Amano T; Nakamizo A; Mishra SK; Gumin J; Shinojima N; Sawaya R; Lang FF
J Neurooncol; 2009 May; 92(3):357-71. PubMed ID: 19357962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]